Mona Kamal Saadeldin

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Gene Expression

Top Venues

Cell death & disease

Al Azhar University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Al Azhar University Oct 14 2014

Egypt

PHD :: Pharmaceutical sciences (Biochemistry and molecular biology)

Al Azhar University Sep 01 2010 - Apr 01 2013

Egypt

MSC :: Pharmaceutical sciences (Biochemistry and molecular biology)

American University in Cairo Jan 29 2009 - Feb 26 2013

Egypt

MSC :: Biotechnology

Ainshams University Sep 01 2001 - May 30 2006

Egypt

BSC :: Pharmacy

Publications

Cecilia Pandini, Giulia Pagani, Martina Tassinari, Emanuele Vitale, Eugenia Bezzecchi, Mona Kamal Saadeldin, Valentina Doldi, Giuliana Giannuzzi, Roberto Mantovani, Matteo Chiara, Alessia Ciarrocchi, Paolo Gandellini
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action. Cell death & disease 15 (3) (2024)
Cecilia Pandini, Giulia Pagani, Martina Tassinari, Emanuele Vitale, Eugenia Bezzecchi, Mona Kamal Saadeldin, Valentina Doldi, Giuliana Giannuzzi, Roberto Mantovani, Matteo Chiara, Alessia Ciarrocchi, Paolo Gandellini
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action. Cell death & disease 15 (3) (2024)
Cecilia Pandini, Giulia Pagani, Martina Tassinari, Emanuele Vitale, Eugenia Bezzecchi, Mona Kamal Saadeldin, Valentina Doldi, Giuliana Giannuzzi, Roberto Mantovani, Matteo Chiara, Alessia Ciarrocchi, Paolo Gandellini
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action. Cell death & disease 15 (3) (2024)
Mona Kamal Saadeldin, Shereen Saeid Elshaer, Ibrahim Ali Emara, Mohamad Maged, Amal Kamal Abdel-Aziz
Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study. PloS one 13 (11) (2018)